Correlation Between Indaptus Therapeutics and Pasithea Therapeutics
Can any of the company-specific risk be diversified away by investing in both Indaptus Therapeutics and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Indaptus Therapeutics and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Indaptus Therapeutics and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on Indaptus Therapeutics and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Indaptus Therapeutics with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Indaptus Therapeutics and Pasithea Therapeutics.
Diversification Opportunities for Indaptus Therapeutics and Pasithea Therapeutics
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Indaptus and Pasithea is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Indaptus Therapeutics and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and Indaptus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Indaptus Therapeutics are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of Indaptus Therapeutics i.e., Indaptus Therapeutics and Pasithea Therapeutics go up and down completely randomly.
Pair Corralation between Indaptus Therapeutics and Pasithea Therapeutics
Given the investment horizon of 90 days Indaptus Therapeutics is expected to generate 1.09 times more return on investment than Pasithea Therapeutics. However, Indaptus Therapeutics is 1.09 times more volatile than Pasithea Therapeutics Corp. It trades about 0.1 of its potential returns per unit of risk. Pasithea Therapeutics Corp is currently generating about -0.31 per unit of risk. If you would invest 85.00 in Indaptus Therapeutics on November 3, 2024 and sell it today you would earn a total of 6.00 from holding Indaptus Therapeutics or generate 7.06% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Indaptus Therapeutics vs. Pasithea Therapeutics Corp
Performance |
| Timeline |
| Indaptus Therapeutics |
| Pasithea Therapeutics |
Indaptus Therapeutics and Pasithea Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Indaptus Therapeutics and Pasithea Therapeutics
The main advantage of trading using opposite Indaptus Therapeutics and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Indaptus Therapeutics position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.| Indaptus Therapeutics vs. Rezolute | Indaptus Therapeutics vs. Tempest Therapeutics | Indaptus Therapeutics vs. Forte Biosciences | Indaptus Therapeutics vs. ABVC Biopharma |
| Pasithea Therapeutics vs. Nutriband Warrant | Pasithea Therapeutics vs. MediciNova | Pasithea Therapeutics vs. Virax Biolabs Group | Pasithea Therapeutics vs. Revelation Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |